Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.39%||69.98||1.0%||$517.12m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.28%||207.19||1.9%||$455.37m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.05%||647.16||2.7%||$414.97m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||4.36||0.7%||$304.78m|
|EXAS||EXACT Sciences Corp.||0.00%||86.26||18.0%||$150.95m|
|TXG||10X Genomics, Inc.||1.89%||154.99||0.0%||$140.09m|
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.